August 2024:17-19 3
TB-500 works systemically: it travels through the entire body and targets injured tissue wherever it finds it
Originator Developed by Eli Lilly Approval status Still investigational - Phase 3 trials are underway before any regulator decides on approval What it has been studied for Study areas from the published literature
Cantini, G., Di Franco, A., Mannucci, E., & Luconi, M
However, preclinical studies of these various endocrine FGF analogs in rodents and monkeys did not reveal GI symptoms, therefore the potential mechanisms underlying adverse GI effects have not been investigated ( Table 2 )
In human studies, statistical differences between Control and HyperSperm groups were analyzed using Wilcoxon matched-pairs signed rank test for safety analysis, Fishers exact test for fertilization and embryo development, or a log-rank test (Mantel-Cox) for developmental times